PMID- 10792952 OWN - NLM STAT- MEDLINE DCOM- 20000614 LR - 20151119 IS - 0022-4804 (Print) IS - 0022-4804 (Linking) VI - 90 IP - 2 DP - 2000 May 15 TI - In vitro validation of duct differentiation in developing embryonic mouse pancreas. PG - 126-30 AB - BACKGROUND: Early embryonic pancreatic epithelia have the capacity for either endocrine or exocrine lineage commitment. Recent studies demonstrated the pluripotential nature of these undifferentiated cells. Isolated pancreatic epithelia grown under the renal capsule formed primarily islets. However, when these same epithelia were grown in a basement-membrane-rich gel (Matrigel) they formed mostly ducts. Currently, there is no model for in vitro pancreatic duct formation and therefore, the mechanism of duct morphogenesis has never been described. The purpose of this study was to provide such a model by characterizing the expression of two duct markers, carbonic anhydrase II (CAII) and the cystic fibrosis transmembrane conductance regulator (CFTR), in isolated undifferentiated pancreatic epithelia grown in vitro. MATERIALS AND METHODS: We microdissected embryonic pancreases at Embryonic Days (E)9.5-11.5 and performed RT-PCR for CAII and CFTR on E9.5 whole pancreases, E10. 5 and E11.5 epithelia, as well as E11.5 epithelia grown for 7 days in Matrigel. Next we performed in situ hybridization for CAII and CFTR and immunohistochemistry for CAII on E11.5 epithelia grown for 7 days in Matrigel. RESULTS: Early, undifferentiated embryonic pancreatic epithelium does not express CAII and CFTR by RT-PCR. When E11.5 epithelia were grown for 7 days in Matrigel, however, gene expression for both markers is upregulated as ducts form. Furthermore, CAII was seen by IHC and both CAII and CFTR were seen by in situ hybridization in the ducts after 7 days in Matrigel. CONCLUSIONS: These data validate our in vitro system as a model for studying the mechanism of normal pancreatic duct differentiation and may potentially help us to understand the faulty mechanism involved in pancreatic ductal carcinogenesis. CI - Copyright 2000 Academic Press. FAU - Kadison, A S AU - Kadison AS AD - New York University Medical Center, New York, New York, USA. FAU - Maldonado, T S AU - Maldonado TS FAU - Crisera, C A AU - Crisera CA FAU - Longaker, M T AU - Longaker MT FAU - Gittes, G K AU - Gittes GK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Surg Res JT - The Journal of surgical research JID - 0376340 RN - 0 (Biomarkers) RN - 0 (RNA, Messenger) RN - 126880-72-6 (Cystic Fibrosis Transmembrane Conductance Regulator) RN - EC 4.2.1.1 (Carbonic Anhydrases) SB - IM MH - Animals MH - Biomarkers MH - Carbonic Anhydrases/genetics MH - Cell Culture Techniques/*methods/*standards MH - Cell Differentiation/physiology MH - Cystic Fibrosis Transmembrane Conductance Regulator/genetics MH - Epithelial Cells/chemistry/cytology/enzymology MH - Female MH - Gene Expression Regulation, Developmental MH - Gene Expression Regulation, Enzymologic MH - In Situ Hybridization MH - Mice MH - Mice, Inbred Strains MH - Pancreatic Ducts/*cytology/*embryology MH - Pregnancy MH - RNA, Messenger/analysis MH - Reproducibility of Results MH - Reverse Transcriptase Polymerase Chain Reaction EDAT- 2000/05/04 09:00 MHDA- 2000/06/17 09:00 CRDT- 2000/05/04 09:00 PHST- 2000/05/04 09:00 [pubmed] PHST- 2000/06/17 09:00 [medline] PHST- 2000/05/04 09:00 [entrez] AID - S0022-4804(00)95876-1 [pii] AID - 10.1006/jsre.2000.5876 [doi] PST - ppublish SO - J Surg Res. 2000 May 15;90(2):126-30. doi: 10.1006/jsre.2000.5876.